Lidocaine HCl Injection Recall Due to Lack of Sterility Assurance
Fagron Compounding Services is recalling Lidocaine HCl Injection due to lack of assurance of sterility. Four lot numbers distributed nationwide are affected with expiration date 10/14/2024.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable product without assured sterility. No illnesses or injuries have been reported. This constitutes a risk-of-harm product where injury has not yet been reported, meeting the rubric criteria for High severity.
Plain-English summary
Fagron Compounding Services is recalling Lidocaine HCl Injection, 2% (20mg per mL), supplied as 100 mg per 5 mL per syringe, due to lack of assurance of sterility. The affected product was distributed nationwide in the United States.
The recall involves four specific lot numbers: C274-000037397, C274-000037398, C274-000037399, and C274-000037400, all with an expiration date of 10/14/2024. Sterility assurance is critical for injectable medications to prevent serious infections.
Consumers and healthcare providers who have obtained this product with the affected lot numbers should stop using it immediately and contact Fagron Compounding Services or their healthcare provider for guidance on replacement or disposal.
The recalled product
- Product
- Lidocaine HCl Injection, 2% (20mg per mL) (100 mg per 5 mL) per syringe, Rx only, Fagron Sterile Services, 8710 E. 34th St, N. Wichita, KS 57226.
- Manufacturer
- Fagron Compounding Services
- Category
- Drug — Injectables
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot#: C274-000037397
- C274-000037398
- C274-000037399
- C274-000037400
- Exp. Date 10/14/2024.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Fagron Compounding Services
See all →- HighFagron norepinephrine infusion bags recalled over sterility and detaching port part
FDA (Drugs) · 2026-04-15
- HighFagron vancomycin infusion bags recalled over sterility and detaching port part
FDA (Drugs) · 2026-04-15
- HighFagron vancomycin 1.5 gram bags recalled over sterility and detaching port part
FDA (Drugs) · 2026-04-15
- HighFagron norepinephrine 32 mg bags recalled over sterility and port part
FDA (Drugs) · 2026-04-15
- HighFagron vancomycin 1.25 gram bags recalled over sterility and detaching port part
FDA (Drugs) · 2026-04-15
Same hazard · contamination
See all →- HighMedline Recalls Surgical Convenience Kits Due to Contaminated Components
FDA (Devices) · 2026-09-02
- HighMedline Recalls 263 Surgical Convenience Kits Due to Contamination
FDA (Devices) · 2026-09-02
- HighMedline Recalls 71 Convenience Kits Due to Contaminated Component
FDA (Devices) · 2026-09-02
- HighMedline C-Section Convenience Kits Recalled for Contaminated Components
FDA (Devices) · 2026-09-02
- HighMedline Recalls 419 Surgical Kits Due to Contaminated Component
FDA (Devices) · 2026-09-02